Protein detail
IL7RA
Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127)
Protein symbol IL7RA | UniProt ID | EVMP score 0.38 |
Frequency 1 | Transmembrane count 1 | Protein classification Cancer-related genesCD markersDisease related genesHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins |
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127)
Protein Class
Cancer-related genesCD markersDisease related genesHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins
Protein Function
- Predicted intracellular proteins
- Cancer-related genes:Mutated cancer genes
- CD markers
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Disease related genes
Transmembrane
240..264; Helical
Transmembrane Count
1
Ensembl
Entrez Gene Symbol
Gene Synonym
CD127IL7RAlnc-IL7R
Gene Description
Interleukin 7 receptor
Chromosome
5
Position
35852695-35879603
Frequency
1
EVMP Score
0.38
Fluorescence & Localization
Tissue SpecificretinaCell SpecificRetinal bipolar cells
Function & Pathway
Protein Function
- Predicted intracellular proteins
- Cancer-related genes:Mutated cancer genes
- CD markers
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Disease related genes
Cellular Component
Molecular Function
Biological Process
KEGG
Reactome
- R-hsa-8856825 cargo recognition for clathrin mediated endocytosis
- R-hsa-8856828 clathrin mediated endocytosis
- R-hsa-1280215 cytokine signaling in immune system
- R-hsa-1266695 interleukin 7 signaling
- R-hsa-199991 membrane trafficking
- R-hsa-449147 signaling by interleukins
- R-hsa-5653656 vesicle mediated transport
Mediation Categories
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediation
Relations & Evidence
Enzyme-Mediated Modification
2 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| IL7R | JAK1 | P23458 | Y | 449 | phosphorylation | REACH_ProtMapperProtMapper | ProtMapper:27729062 |
| IL7R | JAK3 | P52333 | Y | 449 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:27423467ProtMapper:22551764 |
Ligand-Receptor Signaling
78 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| receptor | receptor | Baccin2019 | No | Yes | Yes | Yes | No |
| receptor | receptor | SignaLink_function | No | Yes | Yes | Yes | No |
| cytokine | receptor | Almen2009 | No | Yes | Yes | Yes | No |
| ig_like | receptor | Almen2009 | No | Yes | Yes | Yes | No |
| type1_ig_like_cytokine | receptor | Almen2009 | No | Yes | Yes | Yes | No |
| cytokine_receptor | receptor | CellPhoneDB | No | Yes | Yes | Yes | No |
| interleukin | receptor | Baccin2019 | No | Yes | Yes | Yes | No |
| cytokine | receptor | Baccin2019 | No | Yes | Yes | Yes | No |
| cytokine_type_1 | receptor | HPMR | No | Yes | Yes | Yes | No |
| prolactin | receptor | HPMR | No | Yes | Yes | Yes | No |
Regulatory Interaction Network
3 records.
Protein Complex Composition
Isolation & Detection Technology
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential Ultracentrifugation | Small R sequencing (Illumi HiSeq 2000 (Solexa)R SequencingMass spectrometry | 1 | 38207106 |
Sequence, Structure & Domains
Sequences
Length
459
Mass
51,579
Sequence
MTILGTTFGMVFSLLQVVSGESGYAQNGDLEDAELDDYSFSCYSQLEVNGSQHSLTCAFEDPDVNITNLEFEICGALVEVKCLNFRKLQEIYFIETKKFLLIGKSNICVKVGEKSLTCKKIDLTTIVKPEAPFDLSVVYREGANDFVVTFNTSHLQKKYVKVLMHDVAYRQEKDENKWTHVNLSSTKLTLLQRKLQPAAMYEIKVRSIPDHYFKGFWSEWSPSYYFRTPEINNSSGEMDPILLTISILSFFSVALLVILACVLWKKRIKPIVWPSLPDHKKTLEHLCKKPRKNLNVSFNPESFLDCQIHRVDDIQARDEVEGFLQDTFPQQLEESEKQRLGGDVQSPNCPSEDVVITPESFGRDSSLTCLAGNVSACDAPILSSSRSLDCRESGKNGPHVYQDLLLSLGTTNSTLPPPFSLQSGILTLNPVAQGQPILTSLGSNQEEAYVTMSSFYQNQ
Alternative Products
Event=Alternative splicing; Named isoforms=4; Name=1; Synonyms=H20; IsoId=P16871-1; Sequence=Displayed; Name=3; Synonyms=H1; IsoId=P16871-2; Sequence=VSP_001714; Name=4; Synonyms=H6, Secreted; IsoId=P16871-3; Sequence=VSP_001713; Name=2; Synonyms=Secreted; IsoId=P16871-4; Sequence=VSP_012618, VSP_012619
Alternative Sequence
237..459; EMDPILLTISILSFFSVALLVILACVLWKKRIKPIVWPSLPDHKKTLEHLCKKPRKNLNVSFNPESFLDCQIHRVDDIQARDEVEGFLQDTFPQQLEESEKQRLGGDVQSPNCPSEDVVITPESFGRDSSLTCLAGNVSACDAPILSSSRSLDCRESGKNGPHVYQDLLLSLGTTNSTLPPPFSLQSGILTLNPVAQGQPILTSLGSNQEEAYVTMSSFYQNQ -> LSLSYGPVSPIIRRLWNIFVRNQEK (in isoform 4); 237..252; EMDPILLTISILSFFS -> LSLSYGPVSPIIRQEL (in isoform 2); 253..459; Missing (in isoform 2); 293..459; NLNVSFNPESFLDCQIHRVDDIQARDEVEGFLQDTFPQQLEESEKQRLGGDVQSPNCPSEDVVITPESFGRDSSLTCLAGNVSACDAPILSSSRSLDCRESGKNGPHVYQDLLLSLGTTNSTLPPPFSLQSGILTLNPVAQGQPILTSLGSNQEEAYVTMSSFYQNQ -> VSVFGA (in isoform 3)
3D Structural Models
Turn
141..144
Helix
35..38; 123..125; 153..156; 192..194
Beta Strand
40..49; 52..61; 70..79; 81..84; 86..88; 91..97; 101..103; 105..111; 114..121; 133..140; 145..151; 158..160; 163..171; 179..191; 200..209; 211..213; 224..227
3D Structure
X-ray crystallography (7)
Domain & Motif Annotations
Motif
217..221; WSXWS motif; 272..280; Box 1 motif
Domain (CC)
The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding.; DOMAIN: The box 1 motif is required for JAK interaction and/or activation.
Domain (FT)
131..231; Fibronectin type-III
Protein Families
- Type I cytokine receptor family
- Type 4 subfamily
Sequence Similarities
Belongs to the type I cytokine receptor family. Type 4 subfamily.
Clinical Relevance
Disease Involvement
Cancer-related genesDisease variantSCID
Related Diseases
Biomarker
Phase 2; Phase 1
Drug Targets
Clinical trial target